Canada Markets closed

Longeveron Inc. (LGVN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.19+0.03 (+0.37%)
At close: 04:00PM EDT
8.19 0.00 (0.00%)
After hours: 07:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close8.16
Bid8.08 x 1000
Ask8.19 x 1300
Day's Range7.84 - 9.20
52 Week Range2.84 - 45.00
Avg. Volume5,325,206
Market Cap170.769M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.75
Earnings DateMay 14, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • Simply Wall St.

    Multiple insiders bought Longeveron Inc. (NASDAQ:LGVN) stock earlier this year, a positive sign for shareholders

    Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

  • GlobeNewswire

    Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results

    Conference call scheduled for 8:30 a.m. ET todayMIAMI, May 13, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today provided a business update and reported its financial results for the first quarter ended March 31, 2022. First Quarter Business Updates: Lomecel-B for Alzheimer’s Disease: In January 2022, we initiated enrollment in a

  • GlobeNewswire

    Longeveron Announces CEO Transition

    -Geoff Green stepping down as CEO, effective June 1, 2022 -K. Chris Min, M.D., Ph.D., current Chief Medical Officer, appointed Interim CEO -Nationwide search is underway for permanent CEO MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company") announced today the resignation of Chief Executive Officer (CEO) Geoff Green, who is leaving the Company effective June 1st, 2022, to pursue new opportunities. Longeveron’s Board of Directors has approved the appo